General Information of the Compound
| Compound ID |
CP0418457
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2,3-Dihydro-indole-1-carboxylic acid pyridin-3-ylamide
Show/Hide
|
||||||||||||||||||
| Synonyms |
1-(3-pyridylcarbamoyl) indoline
2,3-Dihydro-indole-1-carboxylic acid pyridin-3-ylamide
AKOS001223824
BDBM50321878
CHEMBL42327
MolPort-003-287-500
N-(3-Pyridinyl)-2,3-dihydro-1H-indole-1-carboxamide
N-(pyridin-3-yl)indoline-1-carboxamide
SCHEMBL9035888
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C14H13N3O
|
||||||||||||||||||
| Molecular Weight |
239.278
|
||||||||||||||||||
| Canonical SMILES |
O=C(Nc1cccnc1)N1CCc2ccccc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C14H13N3O/c18-14(16-12-5-3-8-15-10-12)17-9-7-11-4-1-2-6-13(11)17/h1-6,8,10H,7,9H2,(H,16,18)
Show/Hide
|
||||||||||||||||||
| InChIKey |
ODXHNGJYIWHPAG-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT00939, 5-hydroxytryptamine receptor 2C
Clinical Information about the Compound